Results 91 to 100 of about 80,496 (306)

Introduction of the Hepatitis B Vaccine—Birth Dose: Methods of Improving Rates in a Milieu of Vaccine Hesitancy

open access: yes, 2023
The hepatitis B virus is a public health threat, chronically infecting over 240 million persons worldwide. The hepatitis B vaccine is 90% effective in preventing perinatal transmission if the first dose is given within the first 24 h of life, followed by
Tessy Fenton-Lee   +2 more
core   +1 more source

Burden and Correlates of Multiple Chronic Infections and Their Associations With Cancer Incidence in Chinese Adults: A Large Case‐Cohort Study

open access: yesInternational Journal of Cancer, EarlyView.
While several oncogenic pathogens cause site‐specific cancers, uncertainties remain about many other chronic infections and combined pathogen effects, especially in non‐Western populations. Using a large case–cohort study nested within the China Kadoorie Biobank, the authors found that co‐infection was common, with a mean of 10 pathogens per individual.
Ling Yang   +212 more
wiley   +1 more source

Current progress in the development of therapeutic vaccines for chronic hepatitis B virus infection [PDF]

open access: yesIranian Journal of Basic Medical Sciences, 2016
Chronic hepatitis B is still a major public health issue despite the successful prophylactic vaccination attempts. Chronicity of hepatitis B virus(HBV) is mainly due to its ability to debilitate host's immune system.
Faezeh Ghasemi   +3 more
doaj  

Completion of multiple-dose travel vaccine series and the availability of pharmacist immunizers: A retrospective analysis of administrative data in Alberta, Canada.

open access: yesPLoS ONE, 2019
Pharmacists in a number of countries are being trained in the administration of injections with the aim of improving access and adherence to vaccinations.
Sherilyn K D Houle, Dean T Eurich
doaj   +1 more source

A Model of Regulatory Burden in Technology Diffusion: The Case of Plant-Derived Vaccines. [PDF]

open access: yes
Plant-derived vaccines may soon displace conventional vaccines. Assuming there are no major technological barriers undermining the feasibility of this innovative technology, it is worthwhile to generate quantitative models of regulatory burden of ...
Bérard, Céline   +4 more
core  

Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial. [PDF]

open access: yes, 2011
BACKGROUND\ud \ud The RTS,S/AS01(E) candidate malaria vaccine is being developed for immunisation of infants in Africa through the expanded programme on immunisation (EPI).
Abdulla, Salim   +125 more
core   +1 more source

Duration of Hepatitis B Vaccine-Induced Protection among Medical Students and Healthcare Workers following Primary Vaccination in Infancy and Rate of Immunity Decline

open access: yes, 2022
Since the introduction of hepatitis B virus (HBV) vaccines, the numbers of HBV infections and complications have significantly decreased. However, the evidence on whether primary vaccination of infants confers lifelong immunity varies. We aimed to assess
Chirayu Auewarakul   +6 more
core   +1 more source

Safety of human papillomavirus vaccines in healthy young women: a meta-analysis of 24 controlled studies

open access: yesJournal of Pharmaceutical Health Care and Sciences, 2017
Background Human papillomavirus (HPV) vaccines have been shown to be effective for the eradication of HPV and prevention of cervical cancer. However, the number of women who receive HPV vaccinations has decreased over the last several years in Japan, due
Yukari Ogawa   +3 more
doaj   +1 more source

Considerations for use of hepatitis A vaccines for post-exposure prophylaxis and international travel [PDF]

open access: yes
Presentations February 2018 Day 1Publication date from document properties.Hepatitis-04a-Nelson-508 ...

core  

Implementing Adult Hepatitis B Immunization and Screening Using Electronic Health Records: A Practical Guide

open access: yes
Importance: Hepatitis B is a serious problem in the United States (US), with up to 2.4 million Americans living with a chronic infection. Only 26–32% of people living with hepatitis B in the US are diagnosed.
Kelly L. Moore   +6 more
core   +1 more source

Home - About - Disclaimer - Privacy